Spyre Therapeutics Inc (NAS:SYRE)
$ 35.92 0.79 (2.25%) Market Cap: 1.83 Bil Enterprise Value: 1.63 Bil PE Ratio: 0 PB Ratio: 8.35 GF Score: 51/100

Aeglea Bio Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 07, 2022 / 02:00PM GMT
Release Date Price: $18.25 (+24.76%)
Operator

Good morning, and welcome to the 2022 annual meeting of stockholders for Aeglea BioTherapeutics. Our host for today's call is Aeglea's President and Chief Executive Officer, Anthony Quinn. (Operator Instructions)

I will now turn the call over to your host. Dr. Quinn, you may begin.

Anthony Quinn
Aeglea BioTherapeutics, Inc. - President & CEO

Thank you, operator. Good morning, everyone. It's a pleasure to welcome you to our annual meeting of stockholders. The meeting is now called to order.

I'd like to introduce the following members of the Board of Directors who are with us this morning: Russell Cox, Armen Shanafelt, Ivana Liebisch, Alison Lawton, and Marcio Souza. I'd also like to introduce our Chief Financial Officer, Jonathan Alspaugh, who is with us this morning. Natalie Hairston from the American Election Services, LLC, will be acting as Inspector of Elections for this meeting, and I will serve as the Chairman.

I also want to introduce Ryan Mitteness of Fenwick & West LLP, our legal counsel; and John Cummins of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot